MCID: CRV047
MIFTS: 67

Cervical Cancer, Somatic malady

Categories: Genetic diseases (common), Cancer diseases, Reproductive diseases

Aliases & Classifications for Cervical Cancer, Somatic

About this section

Aliases & Descriptions for Cervical Cancer, Somatic:

Name: Cervical Cancer, Somatic 49 11
Cervical Cancer 32 10 47 12 67 35 2
Uterine Cervical Neoplasm 10 65
Cervix Cancer 10 67
Neoplasm of Uterine Cervix 10
Tumor of the Cervix Uteri 10
Malignant Tumor of Cervix 65
 
Uterine Cervical Cancer 67
Cervix Uteri Cancer 10
Cervical Carcinoma 47
Cervical Neoplasm 10
Cervix Carcinoma 65
Cerca 67

Classifications:



External Ids:

OMIM49 603956
Disease Ontology10 DOID:4362
ICD1027 C53, C53.9
ICD9CM29 180, 180.9
MeSH36 D002583
NCIt42 C2940, C9311
MedGen34 C0302592
UMLS65 C0007847, C0007873

Summaries for Cervical Cancer, Somatic

About this section
MedlinePlus:35 The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. cervical cancer is caused by a virus called hpv. the virus spreads through sexual contact. most women's bodies are able to fight hpv infection. but sometimes the virus leads to cancer. you're at higher risk if you smoke, have had many children, use birth control pills for a long time, or have hiv infection. cervical cancer may not cause any symptoms at first. later, you may have pelvic pain or bleeding from the vagina. it usually takes several years for normal cells in the cervix to turn into cancer cells. your health care provider can find abnormal cells by doing a pap test to examine cells from the cervix. you may also have an hpv test. if your results are abnormal, you may need a biopsy or other tests. by getting regular screenings, you can find and treat any problems before they turn into cancer. treatment may include surgery, radiation therapy, chemotherapy, or a combination. the choice of treatment depends on the size of the tumor, whether the cancer has spread and whether you would like to become pregnant someday. vaccines can protect against several types of hpv, including some that can cause cancer. nih: national cancer institute

MalaCards based summary: Cervical Cancer, Somatic, also known as cervical cancer, is related to herpes simplex and bacterial vaginosis, and has symptoms including abnormality of the cervical spineand neoplasm. An important gene associated with Cervical Cancer, Somatic is FGFR3 (Fibroblast Growth Factor Receptor 3), and among its related pathways are DNA damage_ATM/ATR regulation of G1/S checkpoint and Glucocorticoid receptor regulatory network. Affiliated tissues include the cervix, uterus and cervix, and related mouse phenotypes are liver/biliary system and limbs/digits/tail.

Disease Ontology:10 A female reproductive organ cancer that is located in the cervix.

CDC:2 Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later.

UniProtKB/Swiss-Prot:67 Cervical cancer: A malignant neoplasm of the cervix, typically originating from a dysplastic or premalignant lesion previously present at the active squamocolumnar junction. The transformation from mild dysplastic to invasive carcinoma generally occurs slowly within several years, although the rate of this process varies widely. Carcinoma in situ is particularly known to precede invasive cervical cancer in most cases. Cervical cancer is strongly associated with infection by oncogenic types of human papillomavirus.

Description from OMIM:49 603956

Related Diseases for Cervical Cancer, Somatic

About this section

Diseases related to Cervical Cancer, Somatic via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 237)
idRelated DiseaseScoreTop Affiliating Genes
1herpes simplex30.8MDM2, TP53
2bacterial vaginosis30.6CDKN2A, MDM2, TP53
3esophageal cancer29.5BAX, CASP3, CDKN1A, CDKN2A, FHIT, MDM2
4breast cancer29.1BAX, BCL2, BIRC5, CA9, CASP3, CASP8
5prostate cancer29.1BAX, BCL2, BIRC5, CASP3, CASP8, CCNB1
6hepatocellular carcinoma28.9BAX, BCL2, BIRC5, CASP3, CASP8, CCNB1
7lung cancer28.1BAX, BCL2, BIRC5, CA9, CADM1, CASP3
8cervicitis11.2
9spinal cord astrocytoma11.1CDKN2A, TP53
10subglottic angioma11.0MDM2, TP53
11acute pancreatitis11.0CDKN2A, FGFR3, TP53
12spastic ataxia 211.0CDKN1A, CDKN2A, TP53
13basophilic carcinoma11.0CDKN2A, MYC, TP53
14urethra inverted papilloma11.0BIRC5, CDKN1A, TP53
15subungual glomus tumor11.0BCL2, TP53
16fallopian tube teratoma11.0BAX, BCL2, TP53
17facial injuries and disorders11.0MDM2, RB1
18middle ear squamous cell carcinoma11.0CDKN2A, MDM2, TP53
19deep leiomyoma11.0CDKN2A, TP53
20myxoid chondrosarcoma11.0CDKN2A, MDM2, RB1
21transient hypogammaglobulinemia of infancy11.0FGFR3, TP53
22uterine corpus adenosarcoma11.0BCL2, BIRC5, TP53
23prostate colloid adenocarcinoma11.0CDKN1A, CDKN2A, TP53
24integumentary system benign neoplasm11.0CASP3, CDKN2A, TP53
25familial short qt syndrome11.0BIRC5, CDKN2A, TP53
26dermato-cardio-skeletal syndrome, borrone type11.0BIRC5, TERT, TP53
27schwannoma of twelfth cranial nerve10.9CDKN2A, MDM2, TP53
28actinic lichen planus10.9FGFR3, MDM2, TP53
29adult astrocytic tumour10.9FGFR3, MDM2, TP53
30papillary adenocarcinoma10.9BIRC5, CDKN1A, TP53
31parapsoriasis10.9MYC, RB1
32uterine ligament serous adenocarcinoma10.9BAX, BCL2, BIRC5
33cervical ribs, sprengel anomaly, anal atresia, and urethral obstruction10.9BIRC5, CDKN2A, TERT
34charcot-marie-tooth disease10.9CDKN2A, DAPK1, TP53
35soft tissue sarcoma childhood10.9BCL2, MDM2, TP53
36autosomal dominant charcot-marie-tooth disease type 2a210.9CDKN2A, MDM2, RB1
37angiolipoma10.9CDKN2A, MDM2
38homocystinuria10.9CASP3, CDKN2A, MYC, TP53
39splenogonadal fusion limb defects micrognatia10.9CDKN2A, TP53
40ischemic neuropathy10.9CASP3, MYC, TP53
41molluscum contagiosum10.9CDKN2A, FGFR3, MMP2, TP53
42large cell medulloblastoma10.9CASP3, MYC, TP53
43ameloblastoma10.9CDKN2A, RB1
44dubin-johnson syndrome10.9CDKN2A, TERT, TP53
45breast disease10.9BAX, BCL2, CDKN1A, TP53
46vulva verrucous carcinoma10.9CDKN1A, CDKN2A, MDM2, TP53
47basaloid squamous cell carcinoma10.9CDKN2A, TP53
48benign eccrine breast spiradenoma10.9CDKN2A, FGFR3, MMP2, TP53
49vasculitis10.9CDKN1A, CDKN2A, MMP2, TP53
50cervical intraepithelial neoplasia10.9

Graphical network of the top 20 diseases related to Cervical Cancer, Somatic:



Diseases related to cervical cancer, somatic

Symptoms for Cervical Cancer, Somatic

About this section


Clinical features from OMIM:

603956

HPO human phenotypes related to Cervical Cancer, Somatic:

id Description Frequency HPO Source Accession
1 abnormality of the cervical spine HP:0003319
2 neoplasm HP:0002664

Drugs & Therapeutics for Cervical Cancer, Somatic

About this section

FDA approved drugs:

id Drug Name Active Ingredient(s)15 Company Approval Date
1
Avastin15 41 BEVACIZUMAB Genentech July 2009
FDA Label: Avastin
Disease/s that Drug Treats:renal cell carcinoma & Colorectal Cancer
Indications and Usage:15 Avastin is a vascular endothelial growth factor-specific angiogenesisinhibitor indicated for the treatment of: Metastatic colorectal cancer, with intravenous 5-fluorouracil-basedchemotherapy for first- or second-line treatment. (1.1) Metastatic colorectal cancer, with fluoropyrimidine- irinotecan- orfluoropyrimidine-oxaliplatin-based chemotherapy for second-linetreatment in patients who have progressed on a first-line Avastincontainingregimen. (1.1) Non-squamous non-small cell lung cancer, with carboplatin and paclitaxelfor first line treatment of unresectable, locally advanced, recurrent ormetastatic disease. (1.2) Glioblastoma, as a single agent for adult patients with progressive diseasefollowing prior therapy. (1.3)-Effectiveness based on improvement in objective response rate. No dataavailable demonstrating improvement in disease-related symptoms orsurvival with Avastin. Metastatic renal cell carcinoma with interferon alfa (1.4) Cervical cancer, in combination with paclitaxel and cisplatin or paclitaxeland topotecan in persistent, recurrent, or metastatic disease. (1.5) Platinum-resistant recurrent epithelial ovarian, fallopian tube or primaryperitoneal cancer, in combination with paclitaxel, pegylated liposomaldoxorubicin or topotecan (1.6) Limitation of Use: Avastin is not indicated for adjuvant treatment of coloncancer. (1.1)
DrugBank Targets:13 1. Vascular endothelial growth factor A;2. Low affinity immunoglobulin gamma Fc region receptor III-B;3. Complement C1r subcomponent;4. Complement C1q subcomponent subunit A;5. Complement C1q subcomponent subunit B;6. Complement C1q subcomponent subunit C;7. Low affinity immunoglobulin gamma Fc region receptor III-A;8. High affinity immunoglobulin gamma Fc receptor I;9. Low affinity immunoglobulin gamma Fc region receptor II-a;10. Low affinity immunoglobulin gamma Fc region receptor II-b;11. Low affinity immunoglobulin gamma Fc region receptor II-c
Mechanism of Action:15 
Target: VEGF
Action: inhibitor
FDA: Bevacizumab binds VEGF and prevents the interaction of VEGF to its receptors (Flt-1 and KDR)697 on the surface of endothelial cells. The interaction of VEGF with its receptors leads to endothelial698 cell proliferation and new blood vessel formation in in vitro models of angiogenesis. Administration699 of bevacizumab to xenotransplant models of colon cancer in nude (athymic) mice caused reduction700 of microvascular growth and inhibition of metastatic disease progression
2
Cervarix15 41 Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant GlaxoSmithKline October 2009
FDA Label: -
Disease/s that Drug Treats:prevention of cervical cancer and cervical intraepithelial neoplasia caused by HPV types 16 and 18
Indications and Usage:15 -
DrugBank Targets: -
Mechanism of Action:15 
Target: IgG neutralizing antibodies directed against HPV-L1 capsid proteins
Action: activates/ provokes production
FDA: -
3
Gardasil15 41 quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine Merck June 2006
FDA Label: Gardasil
Disease/s that Drug Treats:Cervical Cancer Caused by Human Papillomavirus
Indications and Usage:15 GARDASIL is a vaccine indicated in girls and women 9 through 26years of age for the prevention of the following diseases caused byHuman Papillomavirus (HPV) types included in the vaccine: Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16and 18 (1.1) Genital warts (condyloma acuminata) caused by HPV types 6 and11 (1.1)And the following precancerous or dysplastic lesions caused by HPVtypes 6, 11, 16, and 18: Cervical intraepithelial neoplasia (CIN) grade 2/3 and Cervicaladenocarcinoma in situ (AIS) (1.1) Cervical intraepithelial neoplasia (CIN) grade 1 (1.1) Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3 (1.1) Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3 (1.1) Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3 (1.1)GARDASIL is indicated in boys and men 9 through 26 years of age forthe prevention of the following diseases caused by HPV types includedin the vaccine: Anal cancer caused by HPV types 16 and 18 (1.2) Genital warts (condyloma acuminata) caused by HPV types 6 and11 (1.2)And the following precancerous or dysplastic lesions caused by HPVtypes 6, 11, 16, and 18: Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. (1.2)Limitations of GARDASIL Use and Effectiveness: GARDASIL does not eliminate the necessity for women tocontinue to undergo recommended cervical cancer screening.(1.3, 17) Recipients of GARDASIL should not discontinue anal cancerscreening if it has been recommended by a health care provider.(1.3, 17) GARDASIL has not been demonstrated to provide protectionagainst disease from vaccine and non-vaccine HPV types to whicha person has previously been exposed through sexual activity.(1.3, 14.4, 14.5) GARDASIL is not intended to be used for treatment of activeexternal genital lesions; cervical, vulvar, vaginal, and analcancers; CIN; VIN; VaIN, or AIN. (1.3) GARDASIL has not been demonstrated to protect againstdiseases due to HPV types not contained in the vaccine. (1.3,14.4, 14.5) Not all vulvar, vaginal, and anal cancers are caused by HPV, andGARDASIL protects only against those vulvar, vaginal, and analcancers caused by HPV 16 and 18. (1.3) GARDASIL does not protect against genital diseases not causedby HPV. (1.3) Vaccination with GARDASIL may not result in protection in allvaccine recipients. (1.3) GARDASIL has not been demonstrated to prevent HPV-relatedCIN 2/3 or worse in women older than 26 years of age. (14.7)
DrugBank Targets: -
Mechanism of Action:15 
Target: humoral immune response
Action: inducer
FDA: HPV only infects human beings. Animal studies with analogous animal papillomaviruses suggest thatthe efficacy of L1 VLP vaccines may involve the development of humoral immune responses. Humanbeings develop a humoral immune response to the vaccine, although the exact mechanism of protectionis unknown.

Drugs for Cervical Cancer, Somatic (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Etidronic acidapprovedPhase 3427414-83-73305
Synonyms:
(1-Hydroxyethylene)diphosphonic acid
(1-Hydroxyethylidene)bis(phosphonic acid)
(1-Hydroxyethylidene)bisphosphonic acid
(1-Hydroxyethylidene)diphoshonic acid
(1-Hydroxyethylidene)diphosphonic acid
(1-hydroxy-1-phosphonoethyl)phosphonic acid
(1-hydroxyethane-1,1-diyl)bis(phosphonic acid)
(Hydroxyethylidene)diphosphonic acid
0-02-00-00171 (Beilstein Handbook Reference)
1,1,1-Ethanetriol diphosphonate
1-HYDROXY-1,1-DIPHOSPHONOETHANE
1-Hydroxy-1,1-diphosphonoethane
1-Hydroxyethane-1,1,-diphosphonic acid
1-Hydroxyethane-1,1-bisphosphonic acid
1-Hydroxyethane-1,1-diphosphonate
1-Hydroxyethane-1,1-diphosphonic acid
1-Hydroxyethanediphosphonic acid
1-Hydroxyethylidene 1,1-diphosphonic acid
1-Hydroxyethylidene-1,1-biphosphonate
1-Hydroxyethylidene-1,1-bisphosphonate
1-Hydroxyethylidene-1,1-diphosphonic acid
1-Hydroxyethylidenediphosphonic acid
1-hydroxyethane 1,1-diphosphonic acid
1000SL
100511-44-2
103736-66-9
106908-76-3
129130-42-3
138360-84-6
14860-53-8 (tetra-potassium salt)
192526-55-9
2809-21-4
303177-33-5
51888-66-5
54342_ALDRICH
54342_FLUKA
66216-98-6
853028-38-3
85985-26-8
86159-18-4
AC1L1FMT
Acetodiphosphonic acid
Acide etidronique
Acide etidronique [INN-French]
Acido etidronico
Acido etidronico [INN-Spanish]
Acidum etidronicum
Acidum etidronicum [INN-Latin]
BPBio1_000997
BRN 1789291
BSPBio_000905
Bio-0708
C07736
CHEBI:170675
CHEBI:4907
CHEMBL871
 
CID3305
Cintichem Technetium 99m Hedspa
D02373
DB01077
Dequest 2010
Dequest 2015
Dequest Z 010
Didronel
Didronel IV
Diphosphonate (base)
EHDP
EINECS 220-552-8
Ethane-1-hydroxy-1,1-bisphosphonate
Ethane-1-hydroxy-1,1-bisphosphonic acid
Ethane-1-hydroxy-1,1-diphosphonate
Ethane-1-hydroxy-1,1-diphosphonic acid
Etidronate
Etidronate Disodium
Etidronate disodium
Etidronic acid
Etidronic acid (USAN/INN)
Etidronic acid [USAN:INN:BAN]
Etidronic acid monohydrate
Etidronsaeure
Etidronsäure
Ferrofos 510
H0587
H6773_ALDRICH
H6773_SIGMA
HEDP
HSDB 5898
Hydroxyethane-1,1-diphosphonic acid
Hydroxyethanediphosphonic acid
I14-1271
Jsp005415
LS-106637
MLS002207267
MLS002695948
MPI Stannous Diphosphonate
MolPort-001-786-542
NCGC00159352-02
NSC 227995
NSC227995
Osteoscan
Oxyethylidenediphosphonic acid
Phosphonic acid, 1-hydroxy-1,1-ethanediyl ester
Prestwick0_000863
Prestwick1_000863
Prestwick2_000863
Prestwick3_000863
RP 61
SMR000038750
SPBio_002826
STK721995
Turpinal SL
UNII-M2F465ROXU
ethane-1-hydroxy-1,1-bisphosphonic acid
etidronate
2
Calcium carbonateapprovedPhase 3194
Synonyms:
7 Select Antacid
Alka-seltzer Fruit Chews
Alka-seltzer Heartburn Reliefchews
Alka-seltzer Heartburn Reliefchews Cool Mint
Alka-seltzer Heartburn Reliefchews Strawberry
Antacid
Antacid Extra Strength Assorted Berries
Antacid Ultra Strength
Antacid Ultra Strength Assorted Berries
Antacid extra strength
Antacid maximum strength ultra
Being Well Antacid
CaCO3
Calcid ANTACID CALCIUM SUPPLEMENT REGULAR STRENGTH
Calcium Antacid
Calcium Antacid extra strength
Calcium Carbonate
Calcium Carbonate (Antacid)
Calcium Carbonate Chewable Antacid
Calcium Carbonate Extra Strength Antacid
Calcium carbonate
Calcium carbonate (1:1)
Calciumcarbonat
Carbonate de calcium
Carbonato de calcio
Carbonic acid calcium salt (1:1)
Care One Calcium Antacid
Childrens Chewable Antacid
Childrens Pepto
Childrens Stomach Relief
Chooz
D-cal
D-cal Kids
Dg Health Antacid Calcium Supplement
Dg Health Antacid Calcium Supplement regular strength
Dg Health Calcium Antacid
Dg Health Calcium Antacid extra strength
Equaline Antacid
Equaline Antacid regular strength
Equate Antacid
Equate Antacid regular strength
Exchange Select Calcium Antacid
Extra Strength
Extra Strength antacid calcium supplement
First Aid Shot Therapy Upset Stomach Relief
Formu Care Calcium Antacid
Good Sense Antacid
Green Guard Stomach Relief
Health Mart Calcium Antacid
Health Mart Calcium Antacid Assorted Fruit
 
Healthmart Calcium Antacid
Healthy Accents Antacid
Healthy Accents Antacid extra strength
Healthy Mama TAME THE FLAME
Heartburn Relief To Go
His Ulc Mint Blue
Kalziumkarbonat
Kirkland Signature Antacid
Kohlensaurer kalk
Leader Antacid
Leader Antacid Regular Strength
Maximum Strength
Medi First Antacid
Medi First Plus Antacid
Medi-first Antacid
Medi-first Plus Antacid
Medique Alcalak
Medique Ban-acid Maximum Strength 750
Meijer Softchews
Miralac
Miralac Antacid
Moore Medical Antacid
Nutralox
Physicianscare Antacid
Plus Pharma Calcium Antacid
Precipitated calcium carbonate
Regular Strength
Regular Strength Antacid Calcium Supplement
Rexall Antacid
Rx Act Antacid extra strength
Select Brand Antacid Assorted Berries
Sunmark Assorted Berries
Sunmark Calcium Antacid
Sunmark Calcium Antacid REGULAR STRENGTH
Sunmark Calcium Antacid extra strength
Sunmark Calcium Antacid regular strength
Sunmark Smooth Antacid
Titralac
Topcare Antacid Calcium
Topcare Antacid Calcium Extra Strength
Topcare Antacid Calcium Regular Strength
Topcare Antacid Calcium Ultra Strength
Trial Antacid
Tums
Tums Chewy Delights
Tums EX
Tums Smoothies
Tums ULTRA
Tums freshers
Ultrastrength
Welby Health Antacid
e 170
3
Ergocalciferolapproved, nutraceuticalPhase 392350-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
4Gastrointestinal AgentsPhase 36401
5MicronutrientsPhase 33901
6AntacidsPhase 31453
7Trace ElementsPhase 33900
8VitaminsPhase 33857
9vitamin dPhase 31524
10Risedronate SodiumPhase 398115436-72-1
11ErgocalciferolsPhase 3923
12Anti-Ulcer AgentsPhase 31453
13Bone Density Conservation AgentsPhase 32600
14Calcium, DietaryPhase 34678
15calcium channel blockersPhase 31743
16CalciferolNutraceuticalPhase 31074
17Vitamin D2NutraceuticalPhase 3923
18
ponatinibapprovedPhase 229943319-70-824826799
Synonyms:
AP 24534
AP24534
 
Iclusig
Ponatinib Hydrochloride
Ponatinibum
ponatinib
19PONATINIB Phase 2
20Protein Kinase InhibitorsPhase 23162
21AntibodiesPhase 24477
22ImmunoglobulinsPhase 24477
23Antibodies, MonoclonalPhase 22413
24
Pancrelipaseapproved88053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
Creon
PA
Pancreatic alpha-amylase precursor
Pancreaze
 
Pancrelipase
Pertzye
Polocaine-mpf
Ultresa
Viokace
Zenpep
25pancreatin880
26Kavanutraceutical1329000-38-85281052

Interventional clinical trials:

idNameStatusNCT IDPhase
1Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast CancerCompletedNCT00054418Phase 3
2Ponatinib for Advanced Medullary Thyroid CancerTerminatedNCT01838642Phase 2
3Analysis of NF2 Mutations in Radiation-Related Neural TumorsCompletedNCT00340496
4Biomarkers to Distinguish Benign From Malignant Thyroid NeoplasmCompletedNCT01433809
5Personalized Cancer TherapyRecruitingNCT01772771
6Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and SpecificityRecruitingNCT02518256
7Exploring the Neuro-Immune Basis of Cancer-Related Fatigue Using Behavioral MeasuresActive, not recruitingNCT02255773

Search NIH Clinical Center for Cervical Cancer, Somatic

Genetic Tests for Cervical Cancer, Somatic

About this section

Anatomical Context for Cervical Cancer, Somatic

About this section

MalaCards organs/tissues related to Cervical Cancer, Somatic:

33
Uterus, Cervix, Breast, Thyroid, Prostate, Testes, Lung

FMA organs/tissues related to Cervical Cancer, Somatic:

16
The cervix

Animal Models for Cervical Cancer, Somatic or affiliated genes

About this section

MGI Mouse Phenotypes related to Cervical Cancer, Somatic:

38 (show all 30)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000537010.2CASP8, CDKN1A, CDKN2A, MDM2, MYC, RB1
2MP:000537110.2BAX, CDKN1A, FGFR3, MDM2, MYC, RB1
3MP:000118610.2BCL2, CASP3, CDKN2A, MDM2, MYC, RB1
4MP:000538010.1BIRC5, CASP8, CDKN1A, CDKN2A, MDM2, MYC
5MP:000301210.0CASP3, CDKN1A, CDKN2A, FGFR3, MDM2, MYC
6MP:000539110.0BAX, BCL2, CASP3, CDKN1A, CDKN2A, FGFR3
7MP:00028739.9BIRC5, CADM1, FGFR3, MDM2, MMP2, MYC
8MP:00053779.8BAX, BCL2, CASP3, CDKN1A, FGFR3, MYC
9MP:00053679.8BAX, BCL2, CASP3, CASP8, CDKN1A, DAPK1
10MP:00053889.8BAX, BCL2, CASP3, CASP8, CDKN1A, CDKN2A
11MP:00053829.8BCL2, CASP3, CDKN1A, FGFR3, MDM2, MMP2
12MP:00107719.6BCL2, CASP3, CASP8, CDKN1A, CDKN2A, FGFR3
13MP:00053869.6BAX, BCL2, CASP3, CDKN1A, CDKN2A, DAPK1
14MP:00053859.5BCL2, CASP3, CASP8, CDKN1A, CDKN2A, MDM2
15MP:00053699.5BAX, BCL2, CASP3, CASP8, CDKN1A, CDKN2A
16MP:00053899.5BAX, BCL2, CADM1, CASP3, CDKN1A, CDKN2A
17MP:00020069.5BAX, BCL2, CASP8, CDKN1A, CDKN2A, FGFR3
18MP:00053819.5BCL2, CA9, CASP3, CDKN1A, CDKN2A, FGFR3
19MP:00053799.2BAX, BCL2, BIRC5, CA9, CADM1, CASP3
20MP:00053909.2BAX, CADM1, CASP3, CDKN1A, CDKN2A, FGFR3
21MP:00053849.0BAX, BCL2, BIRC5, CADM1, CASP3, CASP8
22MP:00036319.0BAX, BCL2, CADM1, CASP3, CASP8, CDKN1A
23MP:00053789.0BAX, BCL2, CADM1, CASP3, CASP8, CDKN1A
24MP:00053768.9BAX, BCL2, BIRC5, CASP3, CASP8, CDKN1A
25MP:00107688.7BAX, BCL2, BIRC5, CA9, CASP3, CASP8
26MP:00053878.7BAX, BCL2, BIRC5, CADM1, CASP3, CASP8
27MP:00053978.7BAX, BCL2, BIRC5, CADM1, CASP3, CASP8

Publications for Cervical Cancer, Somatic

About this section

Variations for Cervical Cancer, Somatic

About this section

UniProtKB/Swiss-Prot genetic disease variations for Cervical Cancer, Somatic:

67
id Symbol AA change Variation ID SNP ID
1FGFR3p.Ser249CysVAR_004149

Clinvar genetic disease variations for Cervical Cancer, Somatic:

5
id Gene Variation Type Significance SNP ID Assembly Location
1TP53NM_000546.5(TP53): c.747G> T (p.Arg249Ser)single nucleotide variantPathogenicrs28934571GRCh37Chr 17, 7577534: 7577534
2FGFR3NM_000142.4(FGFR3): c.746C> G (p.Ser249Cys)single nucleotide variantPathogenicrs121913483GRCh37Chr 4, 1803568: 1803568

Expression for genes affiliated with Cervical Cancer, Somatic

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Cervical Cancer, Somatic patients vs. healthy controls: 32 (show all 70)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1KRT1keratin 1, type IIUterus-5.470.000
2KRTDAPkeratinocyte differentiation-associated proteinUterus-4.960.000
3CTHRC1collagen triple helix repeat containing 1Uterus+4.650.000
4TMPRSS11Btransmembrane protease, serine 11BUterus-4.580.000
5CDKN2Acyclin-dependent kinase inhibitor 2AUterus+4.450.000
6CMPK2cytidine monophosphate (UMP-CMP) kinase 2, mitochondrialUterus+4.320.000
7CRNNcornulinUterus-4.250.000
8MALmal, T-cell differentiation proteinUterus-4.210.000
9DSG1desmoglein 1Uterus-4.170.000
10ECT2epithelial cell transforming 2Uterus+4.100.000
11SYCP2synaptonemal complex protein 2Uterus+3.950.000
12HS6ST2heparan sulfate 6-O-sulfotransferase 2Uterus+3.940.000
13KIF14kinesin family member 14Uterus+3.880.000
14IFI44interferon-induced protein 44Uterus+3.880.000
15MMP1matrix metallopeptidase 1Uterus+3.830.001
16GREB1growth regulation by estrogen in breast cancer 1Uterus-3.780.000
17KRT17keratin 17, type IUterus+3.710.000
18SPINK7serine peptidase inhibitor, Kazal type 7 (putative)Uterus-3.700.000
19NUF2NUF2, NDC80 kinetochore complex componentUterus+3.700.000
20NCEH1neutral cholesterol ester hydrolase 1Uterus+3.640.000
21PLSCR1phospholipid scramblase 1Uterus+3.630.000
22E2F7E2F transcription factor 7Uterus+3.620.000
23SLF1SMC5-SMC6 complex localization factor 1Uterus+3.610.000
24INHBAinhibin, beta AUterus+3.590.001
25DAPL1death associated protein-like 1Uterus-3.570.000
26KRT4keratin 4, type IIUterus-3.530.000
27SMC4structural maintenance of chromosomes 4Uterus+3.500.000
28CEP55centrosomal protein 55kDaUterus+3.490.000
29LOXlysyl oxidaseUterus+3.480.000
30ANLNanillin actin binding proteinUterus+3.480.000
31ITGB1integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)Uterus+3.460.000
32CRISP3cysteine-rich secretory protein 3Uterus-3.460.001
33HELLShelicase, lymphoid-specificUterus+3.440.000
34KRT19keratin 19, type IUterus+3.440.002
35SPP1secreted phosphoprotein 1Uterus+3.430.000
36CNFNcornifelinUterus-3.420.000
37EPCAMepithelial cell adhesion moleculeUterus+3.390.000
38NDC80NDC80 kinetochore complex componentUterus+3.350.000
39SCDstearoyl-CoA desaturase (delta-9-desaturase)Uterus+3.310.000
40CRCT1cysteine-rich C-terminal 1Uterus-3.310.002
41KRT13keratin 13, type IUterus-3.300.010
42CDK1cyclin-dependent kinase 1Uterus+3.300.000
43DDIT4DNA-damage-inducible transcript 4Uterus+3.290.000
44ARMT1acidic residue methyltransferase 1Uterus+3.290.000
45ALOX12arachidonate 12-lipoxygenaseUterus-3.280.000
46ATAD2ATPase family, AAA domain containing 2Uterus+3.270.000
47ZIC2Zic family member 2Uterus+3.260.000
48ARHGAP21Rho GTPase activating protein 21Uterus+3.240.000
49LYNLYN proto-oncogene, Src family tyrosine kinaseUterus+3.240.000
50PPIBpeptidylprolyl isomerase B (cyclophilin B)Uterus+3.230.000
51CSTF3cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDaUterus+3.200.000
52TFRCtransferrin receptorUterus+3.190.000
53TOP2Atopoisomerase (DNA) II alphaUterus+3.180.000
54S100A8S100 calcium binding protein A8Uterus-3.180.000
55ASPMabnormal spindle microtubule assemblyUterus+3.160.000
56B4GALT4UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4Uterus+3.150.000
57EDN3endothelin 3Uterus-3.150.000
58CXCL8chemokine (C-X-C motif) ligand 8Uterus+3.140.000
59RAD51AP1RAD51 associated protein 1Uterus+3.120.000
60HNRNPH2heterogeneous nuclear ribonucleoprotein H2 (H')Uterus+3.120.000
61DTLdenticleless E3 ubiquitin protein ligase homolog (Drosophila)Uterus+3.120.000
62NASPnuclear autoantigenic sperm protein (histone-binding)Uterus+3.090.000
63ESRGembryonic stem cell related (non-protein coding)Uterus-3.070.000
64CENPKcentromere protein KUterus+3.060.000
65PLATplasminogen activator, tissueUterus+3.040.000
66SPINK5serine peptidase inhibitor, Kazal type 5Uterus-3.030.000
67TMEFF2transmembrane protein with EGF-like and two follistatin-like domains 2Uterus-3.020.000
68EREGepiregulinUterus-3.020.000
69ISG15ISG15 ubiquitin-like modifierUterus+3.010.001
70KNTC1kinetochore associated 1Uterus+3.010.000

Search GEO for disease gene expression data for Cervical Cancer, Somatic.

Pathways for genes affiliated with Cervical Cancer, Somatic

About this section

Pathways related to Cervical Cancer, Somatic according to GeneCards Suite gene sharing:

(show top 50)    (show all 96)
idSuper pathwaysScoreTop Affiliating Genes
110.0CDKN1A, MDM2, MYC, TP53
210.0BAX, CDKN1A, MDM2, TP53
310.0BCL2, CCNB1, CDKN1A, MYC
410.0BAX, BCL2, CASP8, MYC
510.0BAX, BCL2, CASP3, TERT
6
Show member pathways
10.0CCNB1, CDKN1A, MDM2, TP53
710.0BAX, BCL2, CASP3, CCNB1
89.9CDKN2A, MDM2, MYC, RB1, TP53
9
Show member pathways
9.9BAX, CDKN1A, MDM2, MYC, TP53
10
Show member pathways
9.9BAX, BCL2, CASP3, CASP8, TP53
119.9BCL2, FHIT, MYC, RB1, TP53
12
Show member pathways
9.9BAX, BCL2, CASP3, CASP8, RB1
139.9BIRC5, CCNB1, MMP2, MYC, RB1
149.8CDKN1A, CDKN2A, MDM2, MYC, RB1, TP53
15
Show member pathways
9.8CDKN1A, CDKN2A, MDM2, MYC, RB1, TP53
169.8BCL2, CDKN1A, CDKN2A, MDM2, RB1, TP53
179.8BCL2, CDKN1A, FGFR3, MDM2, MYC, TP53
189.8BCL2, CDKN1A, MDM2, MYC, RB1, TP53
19
Show member pathways
9.8BAX, BCL2, BIRC5, CASP3, DAPK1, TP53
209.8CCNB1, CDKN1A, MDM2, MYC, RB1, TP53
219.8BAX, BIRC5, CCNB1, MYC, TERT, TP53
229.8CASP3, CDKN1A, MDM2, MMP2, MYC, TP53
239.8BAX, CDKN1A, CDKN2A, MYC, RB1, TERT
24
Show member pathways
9.7CASP3, CDKN1A, FGFR3, MDM2, MYC, RB1
25
Show member pathways
9.7BAX, BCL2, CDKN1A, CDKN2A, MDM2, MYC
26
Show member pathways
9.7BAX, BCL2, CDKN1A, CDKN2A, MDM2, MYC
27
Show member pathways
9.7CCNB1, CDKN1A, CDKN2A, MDM2, MYC, RB1
289.7CCNB1, CDKN1A, CDKN2A, MDM2, MYC, RB1
29
Show member pathways
9.7BAX, BCL2, CASP3, CASP8, DAPK1, RB1
309.7BAX, BIRC5, CASP3, CDKN1A, MMP2, MYC
319.7BCL2, CDKN1A, CDKN2A, MDM2, MMP2, RB1
32
Show member pathways
9.7BAX, BCL2, BIRC5, CASP3, CASP8, CDKN1A
33
Show member pathways
9.7BAX, BCL2, CCNB1, CDKN1A, CDKN2A, MDM2
34
Show member pathways
9.7BAX, BCL2, CASP3, CASP8, FGFR3, MDM2
35
Show member pathways
9.7BCL2, CDKN1A, CDKN2A, FHIT, MDM2, RB1
36
Show member pathways
9.7CASP8, CCNB1, CDKN1A, MDM2, MYC, RB1
379.6BCL2, CASP3, CDKN1A, CDKN2A, FGFR3, MDM2
38
Show member pathways
9.6BAX, BCL2, CASP3, CASP8, CDKN1A, MDM2
39
Show member pathways
9.6BAX, BCL2, BIRC5, CASP3, CDKN1A, MDM2
40
Show member pathways
9.6BAX, BCL2, CASP3, CASP8, MDM2, MYC
419.6BAX, BCL2, CASP3, CASP8, MDM2, MYC
429.6BAX, BCL2, CASP3, CASP8, CDKN1A, MDM2
439.5BAX, BCL2, CCNB1, CDKN1A, MDM2, MMP2
449.5CDKN1A, CDKN2A, DAPK1, FGFR3, MDM2, MMP2
459.5BAX, CASP3, CASP8, CDKN1A, CDKN2A, MDM2
46
Show member pathways
9.5BAX, BCL2, BIRC5, CASP3, CASP8, CDKN1A
47
Show member pathways
9.4BAX, BCL2, BIRC5, CASP3, CASP8, CDKN2A
48
Show member pathways
9.3BAX, CASP3, CASP8, CCNB1, CDKN1A, CDKN2A
49
Show member pathways
9.1BCL2, BIRC5, CCNB1, CDKN1A, CDKN2A, FGFR3
508.9BAX, BCL2, BIRC5, CASP3, CASP8, CDKN1A

GO Terms for genes affiliated with Cervical Cancer, Somatic

About this section

Cellular components related to Cervical Cancer, Somatic according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1PML bodyGO:001660510.2RB1, TERT, TP53

Biological processes related to Cervical Cancer, Somatic according to GeneCards Suite gene sharing:

(show all 50)
idNameGO IDScoreTop Affiliating Genes
1regulation of mitochondrial membrane permeabilityGO:004690210.9BCL2, TP53
2leukocyte homeostasisGO:000177610.9BAX, BCL2
3regulation of mitochondrial membrane potentialGO:005188110.9BAX, BCL2
4positive regulation of developmental pigmentationGO:004808710.9BAX, BCL2
5regulation of cysteine-type endopeptidase activity involved in apoptotic processGO:004328110.9BAX, CASP3
6B cell homeostasisGO:000178210.9BAX, CASP3
7negative regulation of B cell proliferationGO:003088910.9CASP3, CDKN2A
8cellular component disassembly involved in execution phase of apoptosisGO:000692110.9CASP3, CASP8
9positive regulation of protein oligomerizationGO:003246110.8BAX, TP53
10glial cell apoptotic processGO:003434910.8BAX, CASP3, RB1
11response to iron ionGO:001003910.8BCL2, MDM2
12cellular response to UVGO:003464410.8BAX, MYC, TP53
13cell cycle arrestGO:000705010.8CDKN2A, RB1, TP53
14cellular response to glucose starvationGO:004214910.8BCL2, TP53
15cellular response to organic substanceGO:007131010.8BAX, BCL2, CASP3
16endoplasmic reticulum calcium ion homeostasisGO:003246910.7BAX, BCL2
17response to glucocorticoidGO:005138410.7BCL2, CASP3, CDKN1A
18regulation of protein stabilityGO:003164710.7BCL2, CDKN2A, TERT
19negative regulation of cyclin-dependent protein serine/threonine kinase activityGO:004573610.7CASP3, CDKN1A, CDKN2A
20extrinsic apoptotic signaling pathway in absence of ligandGO:009719210.7BAX, BCL2, CASP3, DAPK1
21neuron apoptotic processGO:005140210.7BAX, BCL2, CASP3, RB1
22ovarian follicle developmentGO:000154110.7BAX, BCL2, UBE3A
23apoptotic signaling pathwayGO:009719010.6BAX, CASP3, DAPK1
24negative regulation of neuron apoptotic processGO:004352410.6BAX, BCL2, BIRC5
25protein sumoylationGO:001692510.6BIRC5, CDKN2A, TP53
26response to gamma radiationGO:001033210.5BAX, BCL2, MYC, TP53
27intrinsic apoptotic signaling pathwayGO:009719310.5BAX, CASP3, CASP8, CDKN1A
28extrinsic apoptotic signaling pathway via death domain receptorsGO:000862510.5BAX, BCL2, DAPK1
29programmed cell deathGO:001250110.5BCL2, CASP3, CASP8, TP53
30Ras protein signal transductionGO:000726510.5CDKN1A, CDKN2A, FGFR3, RB1
31negative regulation of gene expressionGO:001062910.5CCNB1, CDKN1A, TERT
32mitotic cell cycleGO:000027810.4CCNB1, CDKN1A, CDKN2A, RB1
33negative regulation of cell growthGO:003030810.4BCL2, CDKN1A, CDKN2A, TP53
34extrinsic apoptotic signaling pathwayGO:009719110.4BAX, CASP3, CASP8, DAPK1
35regulation of protein heterodimerization activityGO:004349710.4BAX, BCL2
36negative regulation of G1/S transition of mitotic cell cycleGO:200013410.4BCL2, CDKN1A, RB1
37replicative senescenceGO:009039910.4CDKN1A, CDKN2A, TERT, TP53
38activation of cysteine-type endopeptidase activity involved in apoptotic processGO:000691910.3BAX, CASP3, CASP8
39viral processGO:001603210.3CASP8, MDM2, RB1, TP53, UBE3A
40proteolysisGO:000650810.2CASP3, CASP8, MMP2, UBE3A
41protein complex assemblyGO:000646110.2CCNB1, MDM2, TP53
42positive regulation of cell proliferationGO:000828410.2BIRC5, FGFR3, MDM2, MYC
43cellular response to DNA damage stimulusGO:000697410.1BAX, BCL2, CASP3, CDKN1A, MYC, TP53
44cellular response to hypoxiaGO:007145610.1BCL2, CCNB1, MDM2
45response to drugGO:004249310.0BAX, BCL2, CA9, CDKN1A, MDM2, MYC
46negative regulation of cysteine-type endopeptidase activity involved in apoptotic processGO:004315410.0BIRC5, CASP8, MDM2
47response to toxic substanceGO:000963610.0BAX, BCL2, CCNB1, MDM2
48apoptotic processGO:00069159.9BAX, BCL2, CADM1, CASP3, CASP8, CDKN2A
49negative regulation of apoptotic processGO:00430669.8BCL2, BIRC5, CASP3, CDKN1A, DAPK1, MDM2
50regulation of cell cycleGO:00517269.8CCNB1, CDKN1A, RB1

Molecular functions related to Cervical Cancer, Somatic according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cyclin-dependent protein serine/threonine kinase inhibitor activityGO:000486110.3CASP3, CDKN2A

Sources for Cervical Cancer, Somatic

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet